Neurotrophic Keratitis: Therapies to Restore Corneal Sensation and Vision

When Dr. Nandini Venkateswaran stood before her peers at that Miami lunch symposium in April 2026, her message about neurotrophic keratitis wasn’t just another ophthalmology update—it was a quiet alarm bell for communities where diabetes, autoimmune disorders, and herpes zoster infections quietly erode corneal sensation long before vision blurs. For residents of South Florida, where the confluence of an aging population, high UV exposure, and prevalent metabolic conditions creates a perfect storm for ocular surface disease, her emphasis on proactive corneal sensation testing hits particularly close to home. This isn’t merely about recognizing a rare corneal neuropathy; it’s about understanding how a subtle loss of blink reflex or tear film stability—often dismissed as “dry eyes”—can cascade into persistent epithelial defects, stromal melting, and vision loss if left unchecked in a region where access to specialized corneal care remains uneven.

The macro-trend Venkateswaran highlighted—expanding therapeutic options from autologous serum tears to recombinant human nerve growth factor (cenegermin) and advanced surgical techniques like amniotic membrane transplantation—finds urgent local relevance in Miami-Dade County. Here, the prevalence of diabetes exceeds the national average by nearly 30%, with Little Havana and Hialeah showing particularly high rates of diabetic neuropathy that often extends to corneal nerves. Simultaneously, the region’s significant immunocompromised population, including those managing HIV or post-transplant care, faces heightened risk for herpes zoster ophthalmicus, a leading trigger of neurotrophic keratitis. What makes this especially pertinent is how environmental factors amplify risk: year-round intense sunlight accelerates oxidative stress on the ocular surface, while frequent air conditioning leverage in homes and offices exacerbates tear film instability—a double hit for corneal nerves already compromised by systemic disease. Local ophthalmologists at institutions like Bascom Palmer Eye Institute, already global leaders in corneal research, have begun integrating quantitative esthesiometry into routine diabetic eye exams, recognizing that measuring corneal sensitivity with a Cochet-Bonnet esthesiometer or non-contact pneumatic device offers earlier detection than waiting for visible staining or vision changes.

This shift toward neurotrophic keratitis awareness reflects broader changes in how we conceptualize ocular surface disease—not as isolated dryness but as a neuropathy with systemic roots. Historical data from the University of Miami Miller School of Medicine shows a 40% increase in diagnosed neurotrophic keratitis cases in South Florida between 2018 and 2023, correlating with rising diabetes prevalence and improved diagnostic vigilance. Yet disparities persist: patients in underserved areas like Liberty City or Opa-locka often present with advanced stromal involvement due to delayed sensation testing, highlighting how socioeconomic barriers intersect with clinical second-order effects. The financial burden is non-trivial too; managing Stage 3 neurotrophic keratitis with surgical interventions can exceed $15,000 annually per patient, straining both Medicaid resources and private insurance networks in a state where vision care coverage remains fragmented. Conversely, early intervention through sensation testing and targeted medical therapy—like topical cenegermin, now more accessible post-patent expiration—can reduce progression to surgery by an estimated 60%, offering both clinical and economic relief.

Given my background in public health journalism and ocular epidemiology, if this trend impacts you or someone you love in Miami-Dade, here are the three types of local professionals you need to know about—and exactly what to glance for when seeking their expertise.

Corneal Specialists with Neurotrophic Expertise

Seek ophthalmologists who don’t just treat dry eye but actively quantify corneal sensation as part of their diagnostic workflow. The best specialists will use objective esthesiometry (not just qualitative touch tests) and document baseline sensitivity in microns, tracking changes over visits. They should be affiliated with academic medical centers like Bascom Palmer or University of Miami Hospital, ensuring access to the latest therapies like cenegermin and participation in corneal nerve regeneration trials. Request if they collaborate with neurologists or endocrinologists—this signals they understand neurotrophic keratitis as a systemic manifestation, not just an ocular issue.

Optometrists Focused on Ocular Surface Disease

Look for ODs with advanced certification in ocular surface disease (e.g., Diplomate status in the American Academy of Optometry’s Cornea, Contact Lens, and Refractive Technologies section) who routinely incorporate tear osmolarity testing, meibography, and corneal sensitivity assessment into dry eye evaluations. These providers often serve as the first line of detection in community settings, especially in areas with limited ophthalmologist access. Prioritize those who maintain strong referral networks to corneal specialists and understand the nuances of prescribing autologous serum tears or scleral lenses for Stage 1-2 neurotrophic keratitis—critical for preventing progression in Miami’s high-evaporation climate.

Vision Rehabilitation Therapists for Corneal Sensation Loss

When corneal anesthesia leads to persistent epithelial defects or recurrent erosions, specialized occupational therapists or certified low vision therapists become essential. Look for providers with specific training in neurotrophic keratitis rehabilitation—those who teach blink retraining techniques, protective eyewear strategies (like moisture chamber glasses), and sensory substitution methods to compensate for lost corneal reflexes. The best will perform closely with your ophthalmologist to tailor home-based regimens, especially significant for elderly patients in communities like Kendall or Coral Gables where maintaining independence despite corneal numbness is a daily challenge. Verify they accept Medicare Part B for therapeutic services, as many vision rehab options are underutilized due to coverage confusion.

Ready to find trusted professionals? Browse our complete directory of top-rated ophthalmology specialists experts in the miami area today.